Who Paid My Doc
John Burger
Geriatric Psychiatry Miami Beach, FL Medical Doctor
NPI 1831197631 CMS profile 614436
6538 Collins Ave, # 510, Miami Beach, FL 33141
General payments
$48
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, John Burger of Miami Beach, FL is reported in the CMS Open Payments database as having received $48 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 14th percentile of Geriatric Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $29 | 1 | |
| 2023 | General | $18 | 1 |
Beside peers
- John Burger
- Geriatric Psychiatry median
- Middle half of Geriatric Psychiatry
- National median
In program year 2025, general payments to John Burger were reported at $0. Among 188 Geriatric Psychiatry profiles paid that year, the median was $125 and the middle half received between $52 and $515.
Show as a table
| Year | John Burger | Geriatric Psychiatry median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $151 | $47–$484 | $163 |
| 2020 | $0 | $112 | $30–$410 | $114 |
| 2021 | $0 | $122 | $35–$550 | $132 |
| 2022 | $0 | $133 | $54–$557 | $149 |
| 2023 | $18 | $138 | $61–$485 | $160 |
| 2024 | $29 | $127 | $51–$572 | $164 |
| 2025 | $0 | $125 | $52–$515 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 10 drugsPart D claims
210
Drug cost
$4,869
Branded share of claims
14.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Donepezil Hcl | Generic | 26 | $1,239 | |
| Duloxetine Hcl | Generic | 13 | $786 | |
| Trazodone Hcl | Generic | 72 | $756 | |
| Mirtazapine | Generic | 12 | $474 | |
| Risperidone | Generic | 11 | $374 | |
| Tamsulosin Hcl | Generic | 17 | $322 | |
| Venlafaxine Hcl Er Venlafaxine Hcl | Brand | 12 | $283 | |
| Sertraline Hcl | Generic | 16 | $238 | |
| Valproic Acid Valproic Acid (As Sodium Salt) | Brand | 18 | $203 | |
| Haloperidol | Generic | 13 | $194 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,891 Part D prescribers listed as Neuropsychiatry; they describe a distribution and say nothing about conduct.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Geriatric Psychiatry in Florida
Related records
Geriatric Psychiatry in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Geriatric Psychiatry
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.